Medicare Enrolled
Dr. Stuart Homer, MD
Nephrology · Avenel, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Homer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Homer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Homer
Dr. Stuart Homer is a nephrology specialist in Avenel, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Homer performed 3,976 Medicare services across 1,303 unique beneficiaries.
Between the years covered by Open Payments, Dr. Homer received a total of $4,040 from 42 pharmaceutical and/or device companies across 256 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Homer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 10% volume in NJ
$4,040 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,976
Medicare services
Top 10% in NJ for nephrology
1,303
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~189 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
940 | $67 | $139 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
887 | $100 | $151 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
616 | $102 | $141 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
273 | $302 | $400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
255 | $140 | $254 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
229 | $32 | $71 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
171 | $40 | $74 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
135 | $44 | $85 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
105 | $180 | $321 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
100 | $251 | $343 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
59 | $74 | $86 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
59 | $33 | $37 |
| Monthly dialysis physician visit A monthly doctor's visit for patients aged 20 or older who are receiving dialysis treatment. |
46 | $165 | $242 |
| New patient office visit, complex (60-74 min) | 36 | $188 | $255 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
29 | $97 | $138 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
22 | $92 | $138 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
14 | $10 | $23 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,040
Total received (2018-2024)
Avg $577/year across 7 years
Top 17% in NJ for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
256
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,991 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$49 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$712
2023
$708
2022
$691
2021
$534
2020
$515
2019
$474
2018
$407
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$105
Bayer Healthcare Pharmaceuticals Inc.
$97
Novartis Pharmaceuticals Corporation
$84
Amgen Inc.
$63
Ardelyx, Inc.
$57
Novo Nordisk Inc
$57
GlaxoSmithKline, LLC.
$49
Fresenius USA Marketing, Inc.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
CALLIDITAS THERAPEUTICS US INC.
$31
Aurinia Pharma U.S., Inc.
$19
Azurity Pharmaceuticals, Inc.
$18
Mallinckrodt Hospital Products Inc.
$17
Dexcom, Inc.
$17
Travere Therapeutics, Inc.
$17
Otsuka America Pharmaceutical, Inc.
$14
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$674
Novo Nordisk Inc
$381
Fresenius USA Marketing, Inc.
$240
Boehringer Ingelheim Pharmaceuticals, Inc.
$215
Bayer Healthcare Pharmaceuticals Inc.
$173
OPKO Pharmaceuticals, LLC
$167
Amgen Inc.
$147
Horizon Therapeutics plc
$145
Vifor Pharma, Inc.
$142
Daiichi Sankyo Inc.
$134
Bayer HealthCare Pharmaceuticals Inc.
$124
Aurinia Pharma U.S., Inc.
$119
Otsuka America Pharmaceutical, Inc.
$113
GlaxoSmithKline, LLC.
$113
Merck Sharp & Dohme Corporation
$109
Novartis Pharmaceuticals Corporation
$98
Baxter Healthcare
$96
SANOFI-AVENTIS U.S. LLC
$77
Travere Therapeutics, Inc.
$75
Ardelyx, Inc.
$57
Amarin Pharma Inc.
$56
Calliditas Therapeutics US Inc.
$54
Lilly USA, LLC
$53
AKEBIA THERAPEUTICS INC
$50
Mallinckrodt Hospital Products Inc.
$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$43
CALLIDITAS THERAPEUTICS US INC.
$42
Mallinckrodt Enterprises LLC
$39
PFIZER INC.
$39
Alexion Pharmaceuticals, Inc.
$29
ARBOR PHARMACEUTICALS, INC.
$26
Azurity Pharmaceuticals, Inc.
$18
Dexcom, Inc.
$17
FRESENIUS USA MANUFACTURING, INC.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$15
Relypsa, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$15
Keryx Biopharmaceuticals, Inc.
$14
Horizon Pharma plc
$14
Abbott Laboratories
$14
AbbVie Inc.
$13
E.R. Squibb & Sons, L.L.C.
$13
Top 3 companies account for 32.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Aimovig · Auryxia · BENLYSTA · BREO · CHANTIX · Dexcom G6 Transmitter · EDARBYCLOR · ELIQUIS · Edarbyclor · FARXIGA · Fabhalta · FreeStyle Libre 2 · Horizant · IBSRELA · INJECTAFER · JANUVIA · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · Korsuva · LEQVIO · LOKELMA · LUPKYNIS · Livalo · Ozempic · Parsabiv · RAYALDEE · Rayaldee · Renal - PD · SOLIQUA · SOLIQUA 100/33 · SOLIRIS · STEGLUJAN · TARPEYO · TAVNEOS · TOUJEO · TRADJENTA · TRULICITY · Tavneos · Tresiba · UBRELVY · Uloric · Vascepa · Velphoro · Veltassa · Victoza · Wegovy · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Nephrologists within 10 mi
533
Per 100K population
61.9
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
1.7 mi
1.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Homer is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NJ), with low-engagement industry engagement in the top 17% of NJ peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Homer experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Homer performed 940 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Homer receive payments from pharmaceutical companies?
Yes. Dr. Homer received a total of $4,040 from 42 companies across 256 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Homer's costs compare to other nephrologists in Avenel?
Dr. Homer's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Homer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Avenel
Browse nephrologists in Avenel ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in NJ
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in NJ
Which NJ nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Fresenius USA Marketing, Inc. Payments to Doctors
See all physicians who received payments from Fresenius USA Marketing, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology